CVE-2014-9017
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote...
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote authenticated users to inject arbitrary web script or HTML via the Subject field in a Task to frontend/index.jsp.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote authenticated users to inject arbitrary web script or HTML via the Subject field in a Task to frontend/index.jsp.
- Record
CVE-2014-9017- CVSS 2.0
- 3.5 Low
AV:N/AC:M/Au:S/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote authenticated users to inject arbitrary web script or HTML via the Subject field in a Task to frontend/index.jsp.
- Record
CVE-2014-9017- Updated
- 2026-11-02
EUVDEUVD-2014-8845 No score
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote authenticated users to inject arbitrary web script or HTML via the Subject field in a Task to frontend/index.jsp.
- Record
EUVD-2014-8845- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-v8m6-85jc-j592 No score
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote...
Cross-site scripting (XSS) vulnerability in OpenKM before 6.4.19 (build 23338) allows remote authenticated users to inject arbitrary web script or HTML via the Subject field in a Task to frontend/index.jsp.
- Record
GHSA-v8m6-85jc-j592- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-9017 is a low vulnerability (CVSS 3.5) in Openkm, published March 11, 2015. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.70%, the 77th percentile. No source names a fixed version.